Portland Investment Counsel Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$22.9M |
| 2 |
CVS Health
CVS
|
+$13.7M |
| 3 |
Danaher
DHR
|
+$9.78M |
| 4 |
Magna International
MGA
|
+$9.49M |
| 5 |
Brookfield Asset Management
BAM
|
+$5.81M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vodafone
VOD
|
+$16.6M |
| 2 |
First Horizon
FHN
|
+$10.3M |
| 3 |
Bank of Montreal
BMO
|
+$7.2M |
| 4 |
Citigroup
C
|
+$5.29M |
| 5 |
Verizon
VZ
|
+$904K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 58.7% |
| 2 | Communication Services | 18.64% |
| 3 | Consumer Discretionary | 10.47% |
| 4 | Healthcare | 10.37% |
| 5 | Technology | 0.66% |
Similar funds
Portland Investment Counsel's Q4 2023 Portfolio in Review
As of Q4 2023, Portland Investment Counsel held 42 positions worth $279M, up 28% from $218M the previous quarter. Its ten largest holdings account for 76% of the portfolio.
Portland Investment Counsel deployed $27.5M of net new capital in Q4 2023, opening 4 new positions and adding to 14 existing holdings. Its largest new stake was CVS Health: 191,900 shares worth $15.2M.
By sector, the portfolio is most concentrated in Financials at 59% of assets, down from 72% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Bank of Montreal, an estimated $7.2M trimmed.
- Portland Investment Counsel's largest Q4 2023 buy was CVS Health: 191,900 shares worth $15.2M.
- Portland Investment Counsel added most to AT&T in Q4 2023, an estimated $22.9M increase.
- Portland Investment Counsel's biggest Q4 2023 reduction was Bank of Montreal, cutting an estimated $7.2M.
- Portland Investment Counsel fully exited Vodafone in Q4 2023, selling an estimated $16.6M.
- Portland Investment Counsel's ten largest holdings make up 76% of its $279M portfolio in Q4 2023.
- Portland Investment Counsel opened 4 new positions and closed 3 in Q4 2023.
- Portland Investment Counsel's portfolio value rose 28% quarter-over-quarter to $279M.
Based on Portland Investment Counsel's 13F filing for Q4 2023, filed 14 Feb 2024.